SRSimão C. Rodeia

Simão C. Rodeia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Simão C. Rodeia has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Alexis Régent

    Service de Médecine Interne, Centre de Référence Maladies Systémiques Autoimmunes Rares d'Ile de France, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France; INSERM U1016, Institut Cochin, Paris; Université Paris Descartes, Sorbonne Paris Cité, Paris; CNRS UMR 8104, Paris

    1 shared publication
  • Alice Bérézné

    Service de Médecine Interne, Centre de Référence Maladies Systémiques Autoimmunes Rares d'Ile de France, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France

    1 shared publication
  • Ana Sofia Carvalho

    Amsterdam UMC location University of Amsterdam, Public and Occupational Health, Amsterdam, the Netherlands

    1 shared publication
  • Benjamin Chaigne

    Service de Médecine Interne, Centre de Référence Maladies Systémiques Autoimmunes Rares d'Ile de France, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France; INSERM U1016, Institut Cochin, Paris; Université Paris Descartes, Sorbonne Paris Cité, Paris; CNRS UMR 8104, Paris

    1 shared publication
  • Benjamin Terrier

    Service de Médecine Interne, Centre de Référence Maladies Systémiques Autoimmunes Rares d'Ile de France, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France; INSERM U1016, Institut Cochin, Paris; Université Paris Descartes, Sorbonne Paris Cité, Paris; CNRS UMR 8104, Paris

    1 shared publication
  • Claire Le Jeunne

    Service de Médecine Interne, Centre de Référence Maladies Systémiques Autoimmunes Rares d'Ile de France, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris

    1 shared publication

Latest Publications

  • Worse Off Patients Tend to Do Worse

    by Pedro Gaspar da Costa, Simão C. Rodeia, Philip Fortuna


  • Open Access

    Cytokine Adsorption Therapy during Extracorporeal Membrane Oxygenation in Adult Patients with COVID-19

    by Simão C. Rodeia, Francisca Lopes Martins, Philip Fortuna, Luís Bento

    Respiratory failure and systemic inflammation are paramount features of severe SARS-CoV-2 disease (COVID-19). Extracorporeal membrane oxygenation (ECMO) therapy has a potential role in patients with refractory disease. An inflammatory response due to blood contact with hemofilters, functioning as a synergic inflammatory stimulus, can lead to a hyperinflammatory state, relatable to cytokine release syndromes. After the first patient succumbed to a refractory vasodilatory shock believed to be due to hyperinflammatory state, a strategy of blood purification through cytokine adsorption therapy (CAT) with CytoSorb® was designed. In this case series, the authors describe the initial experience with such strategy. CAT was employed with no direct complications and helped controlling the inflammatory state, with all patients halting vasopressor support in 72 h and biomarker levels (C-reactive protein, ferritin, and interleukin-6) showing negative trends in most patients. Analysis of inflammatory biomarkers evolution highlighted 2 biomarker profiles related to the presence or absence of superinfection at the time of CAT implementation. In this case series of severe COVID-19 patients, 3 patients died – irreversible lung fibrosis, complications of critical hypoxemia before ECMO induction and complications of systemic anticoagulation were the causes. This case series aimed to contribute to the body of evidence substantiating CAT utilization in hyperinflammatory patients, namely, COVID-19 patients requiring ECMO rescue.


  • Corticosteroid-sparing benefit of intravenous immunoglobulin in systemic sclerosis-associated myopathy: A comparative study in 52 patients

    by Benjamin Chaigne, Simao Rodeia, Nouria Benmostefa, Alice Bérézné, Jérôme Authier, Pascal Cohen, Alexis Régent, Benjamin Terrier, Nathalie Costedoat-Chalumeau, Loïc Guillevin, et al.


  • Exertional heat stroke and acute liver failure: a late dysfunction

    by Ana Sofia Carvalho, Simão C Rodeia, Joana Silvestre, Pedro Póvoa

    Heat stroke (HS) is defined as a severe elevation of core body temperature along with central nervous system dysfunction. Exertional heat stroke (EHS) with acute liver failure (ALF) is a rare condition. The authors report the case of a 25-year-old man with a history of cognitive enhancers’ intake who developed hyperthermia and neurological impairment while running an outdoor marathon. The patient was cooled and returned to normal body temperature after 6 h. He subsequently developed ALF and was transferred to the intensive care unit. Over-the-counter drug intake may have been related to heat intolerance and contributed to the event. The patient was successfully treated with conservative measures. In the presence of EHS, it is crucial to act promptly with aggressive total body cooling, in order to prevent progression of the clinical syndrome. Liver function must also be monitored, since it can be a late organ dysfunction.